# Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

> **NCT00090727** · PHASE1 · UNKNOWN · sponsor: **Novacea** · enrollment: 45 (—)

## Conditions studied

- Solid Malignancies
- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** AQ4N

## Key facts

- **NCT ID:** NCT00090727
- **Lead sponsor:** Novacea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 45 (—)
- **Last updated:** 2006-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090727, "Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00090727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
